Spiro[3.3]heptane as a Saturated Benzene Bioisostere

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Drug Discovery

Background:

• The spiro[3.3]heptane scaffold offers a unique three-dimensional structure with non-coplanar exit vectors.
• This scaffold has been identified as a saturated bioisostere of the benzene ring, a common motif in pharmaceuticals.
• Replacing aromatic rings with saturated bioisosteres can alter physicochemical properties and metabolic stability.

Purpose of the Study:

• To explore the utility of the spiro[3.3]heptane core as a benzene bioisostere in drug design.
• To synthesize novel analogs of existing drugs by incorporating the spiro[3.3]heptane scaffold.
• To evaluate the biological activity and potency of these new saturated analogs.

Main Methods:

• Design and synthesis of spiro[3.3]heptane-containing analogs.
• Incorporation of the spiro[3.3]heptane core in place of benzene rings in known drugs (sonidegib, vorinostat, benzocaine).
• Biological assays to assess the potency of the synthesized compounds.

Main Results:

• Successful synthesis of patent-free analogs using the spiro[3.3]heptane scaffold.
• Demonstrated high potency of these saturated analogs in relevant biological assays.
• The spiro[3.3]heptane core effectively replaced benzene moieties in anticancer and anesthetic drug structures.

Conclusions:

• The spiro[3.3]heptane core is a viable saturated bioisostere for benzene rings in drug development.
• Novel, patent-free analogs of sonidegib, vorinostat, and benzocaine exhibit significant biological potency.
• This scaffold represents a promising strategy for developing new therapeutic agents with improved properties.